; (B) to improve medical supply chain redundancy; (C) to encourage the domestic production of medical devices, equipment, supplies, countermeasures, vaccines, and drugs; and (D) to develop contingency plans for potential global disruptions; and (4) provide recommendations to agencies of the Federal Government, States, local, tribal, and territorial governments, and the private sector on ways to strengthen the security and resilience of the United States medical supply chain. (c) Consultation In preparing the report under subsection (a), the Secretary of Homeland Security— (1) shall consult with the heads of other relevant Federal agencies; and (2) may consult with public health experts, health security experts, supply chain experts, and other individuals with relevant experience.